Moderna tracks Long-Term CMV vaccine protection
NCT ID NCT04975893
Summary
This study followed adults who had previously received an experimental CMV vaccine to see how long their immune protection lasted. Some participants later received a booster dose to see if it safely renewed their protection. The goal was to understand the vaccine's long-term safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispeciality Research, LLC
Lexington, Kentucky, 40509, United States
-
Crossroads Clinical Research (Victoria)
Victoria, Texas, 77901, United States
-
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah, 84109, United States
-
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah, 84121, United States
-
Johnson County Clin-Trials, Inc.
Lenexa, Kansas, 66219, United States
-
Optimal Research, LLC
Peoria, Illinois, 61610, United States
-
Tekton Research Inc
Austin, Texas, 78745, United States
Conditions
Explore the condition pages connected to this study.